Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
|
|
|
18.
|
|
|
|
19.
|
Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes. [electronic resource] by
- Brinton, Eliot A
- Triscari, Joseph
- Brudi, Philippe
- Chen, Erluo
- Johnson-Levonas, Amy O
- Sisk, Christine McCrary
- Ruck, Rae Ann
- MacLean, Alexandra A
- Maccubbin, Darbie
- Mitchel, Yale B
Producer: 20170324
In:
Lipids in health and disease vol. 15
Availability: No items available.
|
|
|
20.
|
Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control. [electronic resource] by
- Bays, Harold E
- Brinton, Eliot A
- Triscari, Joseph
- Chen, Erluo
- Maccubbin, Darbie
- MacLean, Alexandra A
- Gibson, Kendra L
- Ruck, Rae Ann
- Johnson-Levonas, Amy O
- O'Neill, Edward A
- Mitchel, Yale B
Producer: 20151019
In:
Vascular health and risk management vol. 11
Availability: No items available.
|